SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$4.86
+5.42%
2026-10-23
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Key Fundamentals
P/E Ratio
40.10
EPS (TTM)
$0.10
ROE
-90.1%
Profit Margin
0.0%
Debt/Equity
1.02
Price/Book
0.67
Beta
1.22
Market Cap
$2.3M
Avg Volume (10D)
33K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$5.75
60D Low
$2.92
Avg Volume
128K
Latest Close
$4.86
Get breakout alerts for SHPH
Sign up for Breakout Scanner to receive daily notifications when SHPH triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors SHPH daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SHPH operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.